Dye binds to proteins altered by prostate cancer fo form PSA. Two of the most commonly used classes of medication—statins and nonsteroidal anti-inflammatory drugs (NSAIDs)—may compromise already ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

NEW YORK (Reuters Health) - On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows. PSA is a marker for prostate cancer risk when ...

The rate at which PSA rises after hormonal therapy for prostate cancer is a key factor in determining the effectiveness of the treatment. For patients with recurrent and advanced prostate cancer, ...

Statins lower prostate-specific antigen (PSA) levels and appear to reduce the risk of prostate cancer itself, according to data from two trials presented at the American Urological Association meeting ...

Prostate cancer is one of the most common cancers in men. About one in eight men will be diagnosed with prostate cancer ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

Doctors say it's important to know your risk factors and how to manage your weight and overall health. Quitting smoking can ...